QuickView for CP33;jsessionid=EB8870D59D80B187058C2EDAB636BE1B;jsessionid=650828E71F1A63F49E82A46693F90078;jsessionid=7CD3292940BFF1CB1DDF348FEEA0A161 (gene)

1. Rationally Engineered CYP3A4 Fluorogenic Substrates for Functional Imaging Analysis and Drug-Drug In…
2. CYP3A4 and CYP3A5 Expression is Regulated by CYP3A4*1G in CRISPR/Cas9-Edited HepG2 Cells.
3. Effect of CYP3A4 induction and inhibition on the pharmacokinetics of SHR0302 in healthy subjects.
4. Development of In Silico Models for Predicting Potential Time-Dependent Inhibitors of Cytochrome P45…
5. CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients.

There were no clinical trials for CP33;jsessionid=EB8870D59D80B187058C2EDAB636BE1B;jsessionid=650828E71F1A63F49E82A46693F90078;jsessionid=7CD3292940BFF1CB1DDF348FEEA0A161